Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


06.08.2018

1 Arch Virol
1 J Immunol
1 J Infect Dis
1 J Pediatr
2 J Virol
4 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
3 PLoS One
23 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. VAN REGENMORTEL MHV
    Viral species, viral genomes and HIV vaccine design: is the rational design of biological complexity a utopia?
    Arch Virol. 2018 Jul 26. pii: 10.1007/s00705-018-3955.
    PubMed     Text format     Abstract available


    J Immunol

  2. NANJAPPA SG, Mudalagiriyappa S, Fites JS, Suresh M, et al
    CBLB Constrains Inactivated Vaccine-Induced CD8(+) T Cell Responses and Immunity against Lethal Fungal Pneumonia.
    J Immunol. 2018 Jul 27. pii: jimmunol.1701241. doi: 10.4049/jimmunol.1701241.
    PubMed     Text format     Abstract available


    J Infect Dis

  3. SUSCHAK JJ, Bagley K, Shoemaker CJ, Six C, et al
    The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice.
    J Infect Dis. 2018 Jul 19. pii: 5056373. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  4. HEDRICK SM
    The Imperative to Vaccinate.
    J Pediatr. 2018 Jul 25. pii: S0022-3476(18)30866.
    PubMed     Text format    


    J Virol

  5. CAO QM, Ni YY, Cao D, Tian D, et al
    Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and gammadelta T Cell Responses and Confers Heterologous Protection.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available

  6. OZOROWSKI G, Cupo A, Golabek M, LoPiccolo M, et al
    Effects of adjuvants on HIV-1 envelope glycoprotein SOSIP trimers in vitro.
    J Virol. 2018 Apr 18. pii: JVI.00381-18. doi: 10.1128/JVI.00381.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  7. HANON E, Van der Most R, Del Giudice G, Rappuoli R, et al
    Short-term and mid-term solutions for influenza vaccines.
    Lancet Infect Dis. 2018;18:832-833.
    PubMed     Text format    

  8. SAGARA I, Healy SA, Assadou MH, Gabriel EE, et al
    Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
    Lancet Infect Dis. 2018 Jul 27. pii: S1473-3099(18)30344.
    PubMed     Text format     Abstract available

  9. ISHINO T, Tsuboi T
    Progress toward a transmission-blocking vaccine against malaria.
    Lancet Infect Dis. 2018 Jul 27. pii: S1473-3099(18)30358.
    PubMed     Text format    

  10. SCHRAGER LK, Chandrasekaran P, Fritzell BH, Hatherill M, et al
    WHO preferred product characteristics for new vaccines against tuberculosis.
    Lancet Infect Dis. 2018;18:828-829.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  11. GOLWALKAR M, Pope B, Stauffer J, Snively A, et al
    Mumps Outbreaks at Four Universities - Indiana, 2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:793-797.
    PubMed     Text format     Abstract available


    PLoS One

  12. BAKER DL, Powers JG, Ransom JI, McCann BE, et al
    Reimmunization increases contraceptive effectiveness of gonadotropin-releasing hormone vaccine (GonaCon-Equine) in free-ranging horses (Equus caballus): Limitations and side effects.
    PLoS One. 2018;13:e0201570.
    PubMed     Text format     Abstract available

  13. KAUFMAN J, Ryan R, Hill S
    Qualitative focus groups with stakeholders identify new potential outcomes related to vaccination communication.
    PLoS One. 2018;13:e0201145.
    PubMed     Text format     Abstract available

  14. LEE MF, Chiang CH, Li YL, Wang NM, et al
    Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model.
    PLoS One. 2018;13:e0201281.
    PubMed     Text format     Abstract available


    Vaccine

  15. RAVEN S, Urbanus A, de Gee A, Hoebe C, et al
    Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31014.
    PubMed     Text format     Abstract available

  16. WERNIKE K, Mundt A, Link EK, Aebischer A, et al
    N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)31016.
    PubMed     Text format     Abstract available

  17. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
    Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
    PubMed     Text format     Abstract available

  18. BREAKWELL L, Whaley M, Khan UI, Bandy U, et al
    Meningococcal carriage among a university student population - United States, 2015.
    Vaccine. 2018;36:29-35.
    PubMed     Text format     Abstract available

  19. PORTNOY A, Jit M, Helleringer S, Verguet S, et al
    Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Vaccine. 2018;36:170-178.
    PubMed     Text format     Abstract available

  20. LAPINSCKI B, Pereira LA, Nogueira MB, Vidal LR, et al
    Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31597.
    PubMed     Text format     Abstract available

  21. SILVA MTO, Bezerra FSB, de Pinho RB, Begnini KR, et al
    Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
    Vaccine. 2018;36:74-83.
    PubMed     Text format     Abstract available

  22. MALOSH RE, Martin ET, Ortiz JR, Monto AS, et al
    The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31577.
    PubMed     Text format     Abstract available

  23. KOUTOUZIS EI, Daikos GL, Chatzichristou P, Michos AG, et al
    Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986-2015.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31062.
    PubMed     Text format     Abstract available

  24. WELSCH JA, Senders S, Essink B, Klein T, et al
    Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)30946.
    PubMed     Text format     Abstract available

  25. MACHADO A, Kislaya I, Santos AJ, Gaio V, et al
    Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)31010.
    PubMed     Text format     Abstract available

  26. MARTINEZ AC, Prymula R, Valdivieso MM, Del Carmen Otero Reigada M, et al
    Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)30989.
    PubMed     Text format     Abstract available

  27. JAYESHBHAI C, Hajam IA, Verma AK, Bhanuprakash V, et al
    Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA 206 adjuvanted foot-and-mouth disease vaccine in mice model.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)30933.
    PubMed     Text format     Abstract available

  28. PALLIVATHUCAL LB, Noymer A
    Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30999.
    PubMed     Text format     Abstract available

  29. NOH JY, Choi WS, Song JY, Lee HS, et al
    Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30987.
    PubMed     Text format     Abstract available

  30. STATLER VA, Albano FR, Airey J, Sawlwin DC, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: A phase 3, randomized, noninferiority study.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31005.
    PubMed     Text format     Abstract available

  31. DOMEK GJ, O'Leary ST, Bull S, Bronsert M, et al
    Measuring vaccine hesitancy: Field testing the WHO SAGE Working Group on Vaccine Hesitancy survey tool in Guatemala.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31015.
    PubMed     Text format     Abstract available

  32. PANOVSKA-GRIFFITHS J, Crowe S, Pagel C, Shiri T, et al
    A method for evaluating and comparing immunisation schedules that cover multiple diseases: Illustrative application to the UK routine childhood vaccine schedule.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30749.
    PubMed     Text format     Abstract available

  33. FORD AJ, Alwan NA
    Use of social networking sites and women's decision to receive vaccinations during pregnancy: A cross-sectional study in the UK.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30988.
    PubMed     Text format     Abstract available

  34. POLJAK M
    Editorial: Progress in vaccines and vaccination - Best of ECCMID 2016.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)31019.
    PubMed     Text format    

  35. FERDMAN J, Palladino G, Liao HX, Moody MA, et al
    Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59(R)-adjuvanted pandemic 2009 H1N1 vaccine.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30895.
    PubMed     Text format     Abstract available

  36. RIAZ A, Husain S, Yousafzai MT, Nisar I, et al
    Reasons for non-vaccination and incomplete vaccinations among children in Pakistan.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)30993.
    PubMed     Text format     Abstract available

  37. SUN B, Yu S, Zhao D, Guo S, et al
    Polysaccharides as vaccine adjuvants.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31009.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: